Eton Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Eton Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 49% to $31,642,000. The net income raised on -$936,000 and profit margin reached -3%. Total operating expenses were $22,253,000.
Profit Margin
| 2017 | 0 | -7.15M | |
|---|---|---|---|
| 2018 | 0 | -12.74M | |
| 2019 | 959K | -18.03M | -1881.02% |
| 2020 | 39K | -28.82M | -73920.51% |
| 2021 | 21.83M | -2.96M | -13.56% |
| 2022 | 21.25M | -9.78M | -46.03% |
| 2023 | 31.64M | -936K | -2.96% |
ETON Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 31.64M | 21.25M | 21.83M | 39K | 959K | 0 | 0 |
Cost of revenue | 10.58M | 6.93M | 2.62M | 286K | 453K | 0 | 13K |
Gross profit | 21.06M | 14.31M | 19.20M | -247K | 506K | 0 | -13K |
Operating exp. | |||||||
Research and development | 3.32M | 3.99M | 6.23M | 14.10M | 11.55M | 5.62M | 3.93M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | -1.62M |
Total operating expenses | 22.25M | 22.57M | 20.70M | 26.86M | 19.10M | 10.32M | 7.13M |
Operating income | -1.19M | -8.26M | -1.49M | -27.11M | -18.60M | -10.32M | -7.15M |
Other income (expenses), net | 503K | -761K | -460K | -859K | 281K | -2.58M | -6K |
Income before tax | -689K | -9.02M | -1.95M | -27.97M | -18.32M | -12.74M | -7.15M |
Income tax expense | 247K | 761K | 1.00M | 859K | -281K | -2.58M | 0 |
Net income | -936K | -9.78M | -2.96M | -28.82M | -18.03M | -12.74M | -7.15M |
Earnings per share | |||||||
Basic EPS | -0.03 | -0.39 | -0.12 | -1.37 | -1.02 | -1.99 | -0.41 |
Diluted EPS | -0.03 | -0.39 | -0.12 | -1.37 | -1.02 | -1.99 | -0.41 |
| Data source | Data source | Data source | Data source | Data source | Data source |